Day: January 19, 2021

TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) — Routemaster Capital Inc. (the “Company” or “Routemaster”) (TSXV: RM, GR: RMJR) is pleased to announce that it will be listing its common shares on the NEO Exchange (“NEO”) effective January 21, 2021, and concurrent with the NEO listing, the Company will transition to a single purpose company from an investment issuer, redeploying its assets and resources to be a single purpose company focused on being a leader in the decentralized finance industry. The Company will begin to trade under the symbol “DEFI” upon listing on NEO Exchange.In conjunction with this uplisting, the Company has arranged for the delisting of the Company from the TSX Venture Exchange effective the close of trading on January 20, 2021. This transition is not expected to impact current investors ability to trade shares...

KNOXVILLE, Tenn., Jan. 19, 2021 (GLOBE NEWSWIRE) — SmartFinancial, Inc. (“SmartFinancial” or the “Company”; NASDAQ: SMBK), today announced net income of $9.0 million, or $0.59 per diluted common share, for the fourth quarter of 2020, compared to net income of $6.4 million, or $0.42 per diluted common share for the third quarter of 2020. Operating earnings (Non-GAAP), which excludes securities gains, merger related and restructuring expenses and non-operating items, totaled $9.2 million, or $0.61 per diluted common share, in the fourth quarter of 2020, compared to $6.6 million, or $0.44 per diluted common share, in the third quarter of 2020.Highlights for the Fourth Quarter of 2020Net income of $9.0 million and operating earnings of $9.2 million (Non-GAAP)Operating noninterest income (Non-GAAP) increased $381...

SAN DIEGO, Jan. 19, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), announced that it will be presenting preliminary results from an ongoing SARS-CoV-2 mutation surveillance program for its neutralizing antibodies currently in clinical and pre-clinical development for treatment of patients with COVID-19 disease.Dr. Robert Allen, Senior Vice President, Antiviral and Oncolytic Immunotherapy Development at Sorrento and Chief Scientific Officer of SmartPharm Therapeutics, will be presenting data from the SARS-CoV-2 Spike protein variant screening program at PepTalk 2021 today and on Thursday of this week.January 19, 2021 at 1:25 PM PSTA Novel Low-Immunogenic DNA Plasmid Encoded with a Therapeutic Antibody for Long-Lasting Expression in vivo against COVID-19January 21, 2021 at 2:45 PM PSTAn...

TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan”) (TSX: REI.UN) today announced that it has revised the time for its conference call and live audio webcast to discuss financial results for the three months and year ended December 31, 2020. The conference call and live audio webcast is now scheduled to begin at 9:00AM Eastern time on Thursday, February 11, 2021. Financial results will be released before market opens Thursday, February 11, 2021.The conference call can be accessed by dialing 647-427-3230 or 1-877-486-4304. For those that cannot participate in the live mode, a replay will be available for two weeks following the date of the live conference call. To access the replay, please dial 1-855-859-2056 and enter the passcode 6966094#.Alternatively, to access the simultaneous webcast, go...

DUBLIN, IRELAND, Jan. 19, 2021 (GLOBE NEWSWIRE) —  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 third quarter financial results at 10:00 a.m. ET on Wednesday, February 3, 2021.  The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter financial results will be issued after the U.S. market closes on Tuesday, February 2, 2021. For those unable to listen to the conference call live, a replay will be available beginning at 12:00 p.m. ET on February 3, 2021, either at www.steris-ir.com or via phone.  To access the replay of the call, please use the access code...

NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) — Mercer International (NASDAQ: MERC) will release its fourth quarter results for the period ended December 31, 2020 on Tuesday, February 16, 2021, after the close of the market. David M. Gandossi, President and Chief Executive Officer and David K. Ure, Senior Vice President Finance, Chief Financial Officer and Secretary, will be hosting a conference call on Wednesday, February 17, 2021, at 10:00 am ET to discuss the results. The call can be accessed by dialing one of the following:North America: (888) 241-0326International: (647) 427-3411        Conference ID: 7625056        Listeners can also access the conference call live over the Internet by clicking on or copying and pasting the following link into their web browser:https://edge.media-server.com/mmc/p/4hyqmsx9A recording of the completed...

ANDOVER, Massachussets, Jan. 19, 2021 (GLOBE NEWSWIRE) — Casa Systems, Inc. (Nasdaq: CASA) anunció hoy que Izzi, la mayor organización de servicios de gestión (MSO) de México, implementó la solución Gateway de red de banda ancha virtual (vBNG) Axyom de Casa para expandir de manera significativa la capacidad, mientras se prepara para los servicios de banda ancha y convergentes de futura generación. La implementación ya está en marcha en varias ciudades en México y continuará durante 2021.Debido a que las redes experimentan un aumento de tráfico sin precedentes y demandas impredecibles, los proveedores de servicios buscan formas de satisfacer los requisitos cada vez mayores al mismo tiempo que reducen los costos de la red. El enrutador Axyom vBNG de Casa ofrece el rendimiento, la escalabilidad y la flexibilidad necesarios para abordar...

SOUTH SAN FRANCISCO, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage, oncology-focused biopharmaceutical company with a vision of transforming lives with safer, more effective therapies, today announced that it has commenced an underwritten public offering of $75.0 million of its common stock. In addition, CytomX expects to grant the underwriters a 30-day option to purchase up to an additional $11.25 million of its common stock at the public offering price, less underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares are to be offered by CytomX.CytomX expects to use the net proceeds from this...